Company intelligence / Profile preview

Covation Biomaterials

Newark, Delaware, United States

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Covation Biomaterials commercializes bio-based polymers and sustainable materials with significant market presence in apparel, carpeting, cosmetics, food ingredients, packaging, and specialty chemicals. Their portfolio includes Sorona, Susterra, Zemea, and the newly launched bioPTMEG. They have built on their legacy from DuPont with strong recent investments from Huafon Group and have announced new manufacturing capabilities in China. Financial summary includes $200M net sales in the last reported year before acquisition[3].

Industry: Chemicals & Materials

Partnerships

Oscar Chandler & Co. Inc.Truterra (for regenerative farming)Saucony® (running shoes powered by Susterra)

Beyond the preview

Go deeper on Covation Biomaterials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Covation Biomaterials.

Explore the full profile